Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
53.90
+1.50 (2.86%)
At close: Oct 13, 2025
2.86%
Market Cap5.63B
Revenue (ttm)8.47B
Net Income (ttm)447.97M
Shares Out107.42M
EPS (ttm)4.17
PE Ratio12.56
Forward PEn/a
Dividend1.40 (2.67%)
Ex-Dividend DateNov 20, 2024
Volume125,002
Average Volume256,979
Open53.30
Previous Close52.40
Day's Range52.30 - 54.50
52-Week Range36.20 - 65.80
Beta-0.21
RSI38.47
Earnings DateOct 21, 2025

About Navana Pharmaceuticals

Navana Pharmaceuticals PLC engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh. It exports its products. The company was incorporated in 1986 and is based in Dhaka, Bangladesh. [Read more]

Industry Pharmaceutical Preparations
Founded 1986
Employees 4,408
Stock Exchange Dhaka Stock Exchange
Ticker Symbol NAVANAPHAR
Full Company Profile

Financial Performance

In 2024, Navana Pharmaceuticals's revenue was 6.90 billion, an increase of 20.89% compared to the previous year's 5.71 billion. Earnings were 404.63 million, an increase of 13.36%.

Financial Statements

News

There is no news available yet.